IP Library Patent Application 10538678
Patent Application
App. No. 10/538,678

Device for ocular delivery of active principles by the transpalpebral route

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/538,678
Abstract

The invention relates to a device for ocular delivery of active principle(s) ( 1 ) comprising a first outer layer ( 2 ) which is essentially non-leaking, and a second inner layer ( 3 ) which has a surface ( 7 ) able to come into contact with at least one eyelid. characterized in that the second layer comprises at least one active principle intended to be delivered to the patient through the eyelid.

Claims (9)

1 . Device for ocular delivery of active principle(s) ( 1 ; 10 ; 20 ; 30 ; 40 ) comprising a first outer layer ( 2 ; 12 ; 22 ; 32 ; 42 ) which is essentially non-leaking, and a second inner layer ( 3 ; 13 ; 23 ; 33 ; 43 ) which has a surface ( 7 ) able to come into contact with at least one eyelid, characterized in that the second layer comprises at least one active principle intended to be delivered through the eyelid.

2 . Device according to claim 1 , characterized in that the first, non-leaking layer has an inner face ( 8 ), and the second layer ( 3 ) partially overlies the inner face ( 8 ).

3 . Device according to claim 2 , characterized in that a part ( 6 ) of the inner face ( 8 ) not overlied by the second layer ( 3 ) can be overlied with a cutaneous adhesive.

4 . Device according to one of claims 1 to 3 , characterized in that the device for ocular delivery ( 20 ) comprises at least two parts ( 24 , 25 ).

5 . Device according to one of claims 1 to 4 , characterized in that the device has an orifice ( 34 ) at its centre.

6 . Device according to one of claims 1 to 5 , characterized in that it additionally comprises a reservoir ( 44 ) able to be brought into communication with the second layer ( 43 ) via means of communication ( 45 , 46 ).

7 . Device according to claim 6 , characterized in that the means of communication is a protective seal ( 45 ) able to insulate the reservoir of the second layer in a non-leaking manner before its withdrawal.

8 . Device according to one of claims 1 to 7 , characterized in that the layer ( 2 ) is a rigid or semi-rigid shell ( 52 ).

9 . Device according to claim 8 , characterized in that the rigid or semi-rigid shell has, on an outer face, application means ( 54 ).

Assignments (3)
CHANGE OF LEGAL ENTITY Recorded Jan 3, 2008
From: EYEGATE PHARMA S.A.
To: EYEGATE PHARMA S.A.S.
Reel/Frame 020312/0374 →
CHANGE OF NAME Recorded Oct 31, 2006
From: OPTIS FRANCE S.A.
To: EYEGATE PHARMA S.A.
Reel/Frame 018454/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2005
From: ROY, PIERRE; KLEINSINGER, ALAIN
To: OPTIS FRANCE S.A.
Reel/Frame 017188/0716 →